Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Research & Development (2021 - 2025)

Tenon Medical has reported Research & Development over the past 5 years, most recently at $527000.0 for Q4 2025.

  • Quarterly results put Research & Development at $527000.0 for Q4 2025, down 7.38% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (down 17.44% YoY), and the annual figure for FY2025 was $2.1 million, down 17.44%.
  • Research & Development for Q4 2025 was $527000.0 at Tenon Medical, up from $428000.0 in the prior quarter.
  • Over the last five years, Research & Development for TNON hit a ceiling of $901000.0 in Q2 2023 and a floor of $87000.0 in Q1 2021.
  • Median Research & Development over the past 5 years was $663000.0 (2022), compared with a mean of $623050.0.
  • Biggest five-year swings in Research & Development: surged 545.98% in 2022 and later tumbled 34.86% in 2025.
  • Tenon Medical's Research & Development stood at $793000.0 in 2021, then increased by 2.4% to $812000.0 in 2022, then fell by 14.9% to $691000.0 in 2023, then dropped by 17.66% to $569000.0 in 2024, then decreased by 7.38% to $527000.0 in 2025.
  • The last three reported values for Research & Development were $527000.0 (Q4 2025), $428000.0 (Q3 2025), and $503000.0 (Q2 2025) per Business Quant data.